Skip to main content
DNA Labs India

CDKN2A Gene Melanoma, cutaneous malignant, familial NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CDKN2A Gene Melanoma, cutaneous malignant, familial NGS Genetic Test

Short Name: CDKN2A Melanoma NGS Test

Also known as: Cutaneous Malignant Melanoma, Familial Atypical Mole Melanoma Syndrome, FAMMM Syndrome

CDKN2A Gene Melanoma, cutaneous malignant, familial NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS Technology on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to detect mutations in the CDKN2A gene that are associated with an increased risk of developing familial cutaneous malignant melanoma. It aids in risk assessment, genetic counseling, and personalized management for individuals with a family history of melanoma.

Test Code
2893
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
NGS Technology
Step 1

Sample Collection

No special preparation required. Inform the healthcare provider about any medications or medical conditions.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample will be drawn from a vein in your arm. The process is quick and minimally invasive.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bleeding. Resume normal activities.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Genetic counseling is recommended before testing to understand implications.
2
During the Test:The test involves DNA sequencing using NGS technology on a blood sample.
3
After the Test:Results are available in 3-4 weeks. Follow-up with a healthcare provider for interpretation.

About This Test

Who Should Get This Test

The purpose of this test is to detect mutations in the CDKN2A gene that are associated with an increased risk of developing familial cutaneous malignant melanoma. It aids in risk assessment, genetic counseling, and personalized management for individuals with a family history of melanoma.

How to Prepare

  • Ensure proper identification
  • Use sterile equipment
  • Label samples correctly

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic testing for CDKN2A mutations is essential for individuals with a family history of melanoma to enable early detection and preventive strategies."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Collection MethodVenipuncture

Sample Stability

Sample Rejection Criteria:
  • Hemolyzed samples
  • Insufficient volume
  • Improperly labeled samples

Understanding Your Results

Results indicate the presence or absence of pathogenic mutations in the CDKN2A gene. A positive result suggests increased risk for familial melanoma, while a negative result may reduce risk but does not eliminate it entirely.
📊

Negative

No pathogenic variants detected. Risk may be lower, but continued surveillance is recommended based on family history.

📊

Positive

Pathogenic variant detected. Increased risk for melanoma. Genetic counseling and regular dermatological exams are advised.

⚠️ When to Consult a Doctor:

Consult a doctor if you have a family history of melanoma, notice changes in moles, or receive a positive genetic test result for further evaluation and management.

Limitations

  • May not detect all types of mutations
  • Results require genetic counseling
  • Not a diagnostic test for active melanoma, but for risk assessment

Risks & Considerations

  • Minimal risk from blood draw: bruising, infection at puncture site

Interfering Factors

  • Sample contamination
  • Degraded DNA
  • Incorrect sample handling

Compare With Similar Tests

TestCDKN2A Gene Melanoma, cutaneous malignant, familial NGS Genetic TestBRAF Gene Mutation TestComprehensive Cancer Panel
ComparisonCDKN2A Gene Melanoma, cutaneous malignant, familial NGS Genetic TestBRAF test identifies mutations in the BRAF gene common in melanoma, while CDKN2A test focuses on familial risk.Cancer panel tests multiple genes, whereas CDKN2A test is specific to familial melanoma risk.

Frequently Asked Questions

What is the CDKN2A gene?
The CDKN2A gene is a tumor suppressor gene that regulates cell growth. Mutations in this gene can increase the risk of developing melanoma and other cancers.
Who should consider this genetic test?
Individuals with a family history of melanoma, multiple atypical moles, personal history of melanoma, or symptoms of FAMMM syndrome should consider testing.
How is the test performed?
The test uses Next Generation Sequencing (NGS) to analyze DNA from a blood sample, identifying mutations in the CDKN2A gene.
What does a positive result mean?
A positive result indicates a pathogenic mutation in the CDKN2A gene, which increases the risk of developing familial melanoma. Genetic counseling is recommended.
What is the cost of the test?
The cost at DNA Labs India is INR 20,000, which includes sample collection, DNA sequencing, and result interpretation.
Is home sample collection available?
Yes, free home sample collection is available for online bookings across India.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection.
Is genetic counseling required before testing?
Genetic counseling is recommended to understand the implications of testing and results, but it is not mandatory.
Can the test diagnose active melanoma?
No, this test is for risk assessment by identifying genetic mutations, not for diagnosing active melanoma. A skin biopsy is needed for diagnosis.
What are the symptoms of CDKN2A gene melanoma?
Symptoms include changes in moles such as asymmetry, irregular borders, color variation, size larger than a pencil eraser, itching, or bleeding.
How accurate is the NGS genetic test?
NGS technology is highly accurate for detecting mutations, but results should be interpreted in the context of clinical history and genetic counseling.
What should I do if I test positive?
If positive, consult a healthcare provider for genetic counseling, regular dermatological exams, and personalized risk management strategies.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.